Documente Academic
Documente Profesional
Documente Cultură
A R T I C L E I N F O A B S T R A C T
Article history: Many long-term follow-up studies suggest that bipolar disorder (BD) is highly recurrent and that
Received 18 September 2015 depressive episodes are commoner than hypomania/manic episodes. However, some studies from
Received in revised form 3 March 2016 tropical countries including India suggest that the patients experience a greater proportion of manic
Accepted 16 April 2016
episodes than depressive episodes. The aim of the present study was to examine the course of BD type 1
Available online
(BD I) in a sample of hospitalized Indian subjects. We examined the clinical course of 285 BD I subjects
with at least 5 years of illness using standard life charting method. These subjects were hospitalized
Keywords:
between October 2010 and October 2012. The predominant polarity (having at least two-thirds of their
Bipolar disorder
Predominant polarity
lifetime episodes at one polarity) was mania (79%). Unipolar mania ( 3 mania episodes and no episodes
Unipolar mania of depression) was observed in 48% of the subjects. The frequency of rapid cycling course was noted in
Course 2.5% of the subjects. Predominant manic polarity group had the illness onset mostly with a manic
episode (88.9%) and the predominant depressive polarity group with a depressive episode (73.8%). Mania
was the predominant polarity with a high rate of unipolar mania and a majority of the subjects had
greater number of manic episodes than depressive/mixed episodes. The onset polarity determined the
predominant polarity during the course of illness. Predominantly, mania course could have significant
implications in the treatment of bipolar disorder.
ß 2016 Published by Elsevier B.V.
http://dx.doi.org/10.1016/j.ajp.2016.04.006
1876-2018/ß 2016 Published by Elsevier B.V.
S.B. Rangappa et al. / Asian Journal of Psychiatry 22 (2016) 22–27 23
Table 2
Demographic and clinical characteristics in bipolar I disorder based on predominant polarity.
phase than in the manic phase (Baldessarini et al., 2012; Colom that CLOCK3111 T/C C/C allele is associated with a higher
et al., 2006; Popovic et al., 2014; Volkert et al., 2014). recurrence rate (Benedetti et al., 2003). A CLOCK mutant mouse
Contrary to the general observation that patients with BD might constitute an animal model of mania (Roybal et al.,
experience more of depression than mania, some of the studies 2007).Apart from these possible genetic differences, variations
from India (Chopra et al., 2006; Khanna et al., 1992; Khess et al., in sunlight can also play a role (Bauer et al., 2015; Bauer et al.,
1997), Nigeria (Makanjuola, 1985), Ethiopia (Fekadu et al., 2006), 2014; Narayanaswamy et al., 2014). The countries where mania is
Israel (Osher et al., 2000) and Hong Kong (Lee, 1992) report that predominant are from lower latitudes where ambient sunlight
mania constitutes a greater part of BD course than depression. is greater. Indeed, such epigenetic influences affecting circadian
Our study confirms this observation. One can only speculate the rhythm have been implicated in disease states (Masri and
potential mediating effect of genetic differences and environmen- Sassone-Corsi, 2013).
tal factors such as sunlight and latitude in determining the Unipolar mania has not been a common description in the
predominant course. BD has a strong genetic component and it has literature. Some of the previous studies have reported that
been increasingly recognized that circadian rhythm abnormalities unipolar mania is characterized by female preponderance (Solo-
could play an important role in the relapse and symptom mon et al., 2003), earlier age at onset (Shulman and Tohen, 1994),
expression. For instance, variations in the CLOCK gene suggest greater number of episodes (Khanna et al., 1992), premorbid
Table 3
Treatment characteristics in bipolar I disorder based on predominant polarity.
Past treatment
% time on mood stabilizers 12.10 (13.93) 13.41 (14.69) -0.539 0.590
% time on antipsychotics 12.57 (13.80) 14.38 (13.79) -0.755 0.451
% time on antidepressants 1.51 (3.94) 14.94 (15.43) -5.404 <0.001
Current treatment*
Lithium + atypical antipsychotics 143 (63.27) 26 (66.7) 0.116 0.734
Valproate + atypical antipsychotics 37 (16.4) 4 (10.3) 0.951 0.329
Lithium + Valproate + atypical antipsychotics 15 (6.6) 2 (5.1) 0.126 0.722
Lithium + Valproate 10 (4.4) 3 (7.7) 0.222 0.638
Antidepressants** 55 (24.3) 30 (76.9) 42.216 <0.001
Benzodiazepines** 175 (77.4) 22 (56.4) 7.706 0.006
ECT** 30 (13.3) 14 (35.9) 12.294 <0.001
*
Lamotrigine + lithium or valproate/atypical antipsychotic = 5, Carbamazepine + lithium or valproate/atypical antipsychotic = 10 >2 mood stabilizers = 5, Risperidone
alone = 2.
**
In combination with mood stabilizers and/or antipsychotic drugs.
S.B. Rangappa et al. / Asian Journal of Psychiatry 22 (2016) 22–27 25
hyperthymia (Perugi et al., 2007; Yazici et al., 2002) and greater (Baldessarini et al., 2007) and often without concurrent mood
occurrence of grandiosity (Abrams et al., 1979) and psychotic stabilizers (Baldessarini et al., 2007; Blanco et al., 2002; Moreno
symptoms (Pfohl et al., 1982) in addition to lesser occurrence of et al., 2007). In our sample, those with depressive polarity were
rapid cycling phenomenon (Yazici et al., 2002). It is also interesting treated more often with antidepressants and ECT. Previous studies
to note that this entity has been described more frequently from have reported that those with depressive polarity were more often
the ‘‘non-western’’ cultures (Lee and Yu, 1994). As demonstrated treated with antidepressants and lamotrigine (Colom et al., 2006;
in this study, a high frequency of recurrent unipolar mania has Volkert et al., 2014) and ECT (Baldessarini et al., 2012), whereas
been reported in previous studies from India (Khanna et al., 1992) those with manic polarity were often treated with mood stabilizers
and Nigeria (Makanjuola, 1985). or antipsychotics (Colom et al., 2006; Volkert et al., 2014).
The rate of rapid cycling in our sample is low (2.5%) which is Findings of our study could have significant clinical and
much below the year prevalence of 5 33% and lifetime prevalence research implications. The reported predominance of depression
of 26 43% (Carvalho et al., 2014). There are several possible in the course of bipolar disorder has prompted the conclusion that
reasons for low prevalence in our sample. Firstly, rapid cycling is BD I is predominantly a depressive illness, and that BD II is almost
associated with first depressive episode and predominant depres- exclusively a chronic depressive illness (Yatham and Maj, 2010). It
sive polarity (Bauer et al., 2008; Carvalho et al., 2014) and use of is possible that the long-term course of BD in tropics may not be
antidepressants (Bauer et al., 2008; Carvalho et al., 2014; Wehr and similar to that reported in previous western studies. There is
Goodwin, 1979; Wehr et al., 1988). In our sample, the predominant preliminary evidence that this may be the case even in juvenile
polarity was mania and most started their illness with manic bipolar disorder (Jairam et al., 2004; Rajeev et al., 2004). Mood
episode. In addition, time treated with antidepressants was stabilizers (valproate and lithium) are mostly effective in
considerably less and when used always in combination with preventing manic relapses; therefore, ensuring treatment adher-
mood stabilizers and/or antipsychotics (Table 3). Secondly, the ence with mood stabilizers may vastly improve the prognosis
rates of rapid cycling reported in the literature could well be at the (Pompili et al., 2009). It is reassuring that depression was not the
upper limits of true prevalence because of the selection bias of predominant polarity in our sample since treatment of bipolar
research centres (Bauer et al., 2008). Our sample is from the depression is challenging with a possible risk of worsening the
inpatient services of a psychiatric hospital but not from special course with the use of antidepressants (Ghaemi et al., 2003) and a
bipolar disorder services. Special centres for bipolar disorder may high risk of weight gain and metabolic syndrome with the long-
attract more severely ill patients that include rapid cyclers. Finally, term use of olanzapine and quetiapine (Newcomer, 2007). Those
rapid cycling is more common in bipolar II disorder whereas our with initial episode of depression may benefit from the use of drugs
sample is that of bipolar I type (Carvalho et al., 2014). This could be such as lamotrigine and lurasidone whereas those with initial
one contributory factor although some studies refute association episode of mania may benefit from mood stabilizers and certain
between rapid cycling and bipolar types (Mackin, 2005; Maj et al., atypical antipsychotics. It is in this context the predominant
1994). polarity has important treatment implications.
Predominant polarity during the course of bipolar disorder The subjects in the study were evaluated using a retrospective
seems to have important clinical and therapeutic implications. life charting method and this may be a source for potential recall
Polarity of the first mood episode determined the predominant bias. Studying hospitalized sample could have resulted in the
polarity during the course. Turvey et al. reported that the polarity evaluation of a severely ill population, thus limiting the
sequences tend to remain stable over time (Turvey et al., 1999). In a generalizability. Mild depressive episodes may have been under-
study by Perlis et al., 62% of patients whose initial episode was reported. However, a meticulous examination of the course
mania had a predominantly mania course (Perlis et al., 2005). through standardized life charting method and thorough corrobo-
Other studies have also demonstrated that initial episode polarity ration of the history with the aid of an accompanying family
determines the predominant polarity during the course, i.e. initial member have helped us to overcome these limitations to some
episode of mania and depression determine the predominantly extent. Course of bipolar disorder in the India and other tropical
manic and depressive course, respectively (Baldessarini et al., countries need to be systematically examined using multiple data
2012; Colom et al., 2006; Popovic et al., 2014). sets, and if confirmed, the reasons for this difference in semiology
Depressive polarity was also associated with a higher suicidal need to be understood. It could offer an insight into the biological
risk and more number of hospitalizations suggesting a more severe and environmental correlates, and thus improve our understand-
illness. Our findings are in accordance with the findings of other ing and therapeutics of the syndrome.
studies which reported greater suicidal risk (Baldessarini et al.,
2012; Colom et al., 2006; Popovic et al., 2014) and more Conflict of interest
hospitalizations (Popovic et al., 2014) in those with predominant
depressive polarity. Another interesting aspect is that predomi- none
nant depressive group had a greater family history of depressive
disorder. Indeed, such independence in familial transmission Funding source
between manic and depressive phenotypes has been recently
demonstrated (Merikangas et al., 2014). nil
Patients in our sample on the whole were not on psychotropics
for most part of the course. For the index admission, lithium in
Acknowledgments
combination with atypical antipsychotics was the most preferred
option followed by combination of valproate and atypical
The authors would like to acknowledge the participants of this
antipsychotics. These observations are in sharp contrast to
study for their valuable time and co-operation. This is a non-
declining use of lithium and frequent use of valproate elsewhere
funded study.
in the world (Baldessarini et al., 2007; Blanco et al., 2002).
Similarly, the use of antidepressants was limited in our patients
References
compared with the extensive use of antidepressants in the
treatment of bipolar disorder elsewhere. For example, most Abrams, R., Taylor, M.A., Hayman, M.A., Krishna, N.R., 1979. Unipolar mania
commonly prescribed drugs in US patients was antidepressants revisited. J. Affect. Disord. 1, 59–68.
26 S.B. Rangappa et al. / Asian Journal of Psychiatry 22 (2016) 22–27
Aghanwa, H.S., 2001. Recurrent unipolar mania in a psychiatric hospital setting in Lee, S., 1992. The first lithium clinic in Hong Kong: a Chinese profile. Aust. N Z J.
the Fiji Islands. Psychopathology 34, 312–317. Psychiat. 26, 450–453.
Angst, J., 1978. The course of affective disorders. II. Typology of bipolar manic- Lee, S., Yu, H., 1994. Unipolar mania in non-Western cultures. Br. J. Psychiat. 165,
depressive illness. Arch. Psychiatr. Nervenkr. 226, 65–73. 413.
Angst, J., Sellaro, R., 2000. Historical perspectives and natural history of bipolar Mackin, P., 2005. Rapid cycling is equivalently prevalent in bipolar I and bipolar II
disorder. Biol. Psychiatr. 48, 445–457. disorder, and is associated with female gender and greater severity of illness.
Baldessarini, R.J., Leahy, L., Arcona, S., Gause, D., Zhang, W., Hennen, J., 2007. Evidence-based Mental Health 8, 52.
Patterns of psychotropic drug prescription for U.S. patients with diagnoses of Maj, M., Magliano, L., Pirozzi, R., Marasco, C., Guarneri, M., 1994. Validity of
bipolar disorders. Psychiatr. Serv. 58, 85–91. rapid cycling as a course specifier for bipolar disorder. Am. J. Psychiat. 151,
Baldessarini, R.J., Undurraga, J., Vazquez, G.H., Tondo, L., Salvatore, P., Ha, K., Khalsa, 1015–1019.
H.M., Lepri, B., Ha, T.H., Chang, J.S., Tohen, M., Vieta, E., 2012. Predominant Makanjuola, R.O., 1985. Recurrent unipolar manic disorder in the Yoruba Nigerian:
recurrence polarity among 928 adult international bipolar I disorder patients. further evidence. Br. J. Psychiat. 147, 434–437.
Acta Psychiat. Scand. 125, 293–302. Marneros, A., Breiger, P., 2002. Prognosis of bipolar disorder: a review. In: Bipolar
Bauer, M., Beaulieu, S., Dunner, D.L., Lafer, B., Kupka, R., 2008. Rapid cycling bipolar Disorder, Eds, Maj, M., Akiskal, H.S., Lopez-Ibor, J.J., Sartorius, N. (Eds.),
disorder–diagnostic concepts. Bipolar Disord. 10, 153–162. WPA Series Evidence & Experience in Psychiatry. John Wiley & Sons Ltd, UK,
Bauer, M., Glenn, T., Alda, M., Andreassen, O.A., Angelopoulos, E., Ardau, R., Baethge, pp. 97–148.
C., Bauer, R., Baune, B.T., Bellivier, F., Belmaker, R.H., Berk, M., Bjella, T.D., Bossini, Masri, S., Sassone-Corsi, P., 2013. The circadian clock: a framework linking
L., Bersudsky, Y., Wo Cheung, E.Y., Conell, J., Del Zompo, M., Dodd, S., Etain, B., metabolism, epigenetics and neuronal function. Nat. Rev. Neurosci. 14,
Fagiolini, A., Frye, M.A., Fountoulakis, K.N., Garneau-Fournier, J., Gonzalez-Pinto, 69–75.
A., Gottlieb, J.F., Harima, H., Hassel, S., Henry, C., Iacovides, A., Isometsa, E.T., Maxwell, E., 1992. The Family Interview for Genetic Studies Manual. Washington,
Kapczinski, F., Kliwicki, S., Konig, B., Krogh, R., Kunz, M., Lafer, B., Larsen, E.R., DC, National Institute of Mental Health, Intramural Research Program. Clinical
Lewitzka, U., Lopez-Jaramillo, C., MacQueen, G., Manchia, M., Marsh, W., Mar- Neurogenetics Branch.
tinez-Cengotitabengoa, M., Melle, I., Monteith, S., Morken, G., Munoz, R., Nery, Merikangas, K.R., Cui, L., Heaton, L., Nakamura, E., Roca, C., Ding, J., Qin, H., Guo, W.,
F.G., O’Donovan, C., Osher, Y., Pfennig, A., Quiroz, D., Ramesar, R., Rasgon, N., Reif, Yao-Shugart, Y., Zarate, C., Angst, J., 2014. Independence of familial transmission
A., Ritter, P., Rybakowski, J.K., Sagduyu, K., Miranda-Scippa, A., Severus, E., of mania and depression: results of the NIMH family study of affective spectrum
Simhandl, C., Stein, D.J., Strejilevich, S., Sulaiman, A.H., Suominen, K., Tagata, disorders. Mol. Psychiat. 19, 214–219.
H., Tatebayashi, Y., Torrent, C., Vieta, E., Viswanath, B., Wanchoo, M.J., Zetin, M., Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A.B., Olfson, M., 2007. National
Whybrow, P.C., 2015. Influence of light exposure during early life on the age of trends in the outpatient diagnosis and treatment of bipolar disorder in youth.
onset of bipolar disorder. J. Psychiat. Res. 64, 1–8. Arch. Gen. Psychiat. 64, 1032–1039.
Bauer, M., Glenn, T., Alda, M., Andreassen, O.A., Angelopoulos, E., Ardau, R., Baethge, Narayanaswamy, J.C., Moily, N., Kubendran, S., Reddy, Y.C., Jain, S., 2014. Does
C., Bauer, R., Bellivier, F., Belmaker, R.H., Berk, M., Bjella, T.D., Bossini, L., latitude as a zeitgeber affect the course of bipolar affective disorder?
Bersudsky, Y., Cheung, E.Y., Conell, J., Del Zompo, M., Dodd, S., Etain, B., Fagiolini, Med. Hypotheses 83, 387–390.
A., Frye, M.A., Fountoulakis, K.N., Garneau-Fournier, J., Gonzalez-Pinto, A., Newcomer, J.W., 2007. Metabolic considerations in the use of antipsychotic
Harima, H., Hassel, S., Henry, C., Iacovides, A., Isometsa, E.T., Kapczinski, F., medications: a review of recent evidence. J. Clin. Psychiat. 68 (Suppl 1), 20–27.
Kliwicki, S., Konig, B., Krogh, R., Kunz, M., Lafer, B., Larsen, E.R., Lewitzka, U., Osher, Y., Yaroslavsky, Y., el-Rom, R., Belmaker, R.H., 2000. Predominant polarity of
Lopez-Jaramillo, C., MacQueen, G., Manchia, M., Marsh, W., Martinez-Cengoti- bipolar patients in Israel. World J. Biol. Psychiat. Official J. World Federation Soc.
tabengoa, M., Melle, I., Monteith, S., Morken, G., Munoz, R., Nery, F.G., O’Dono- Biol. Psychiat. 1, 187–189.
van, C., Osher, Y., Pfennig, A., Quiroz, D., Ramesar, R., Rasgon, N., Reif, A., Ritter, P., Perlis, R.H., Delbello, M.P., Miyahara, S., Wisniewski, S.R., Sachs, G.S., Nierenberg,
Rybakowski, J.K., Sagduyu, K., Scippa, A.M., Severus, E., Simhandl, C., Stein, D.J., A.A., 2005. Revisiting depressive-prone bipolar disorder: polarity of initial
Strejilevich, S., Sulaiman, A.H., Suominen, K., Tagata, H., Tatebayashi, Y., Torrent, mood episode and disease course among bipolar I systematic treatment en-
C., Vieta, E., Viswanath, B., Wanchoo, M.J., Zetin, M., Whybrow, P.C., 2014. hancement program for bipolar disorder participants. Biol. Psychiat. 58,
Relationship between sunlight and the age of onset of bipolar disorder: an 549–553.
international multisite study. J. Affect. Disord. 167, 104–111. Perlis, R.H., Ostacher, M.J., Patel, J.K., Marangell, L.B., Zhang, H., Wisniewski, S.R.,
Benedetti, F., Serretti, A., Colombo, C., Barbini, B., Lorenzi, C., Campori, E., Smeraldi, Ketter, T.A., Miklowitz, D.J., Otto, M.W., Gyulai, L., Reilly-Harrington, N.A.,
E., 2003. Influence of CLOCK gene polymorphism on circadian mood fluctuation Nierenberg, A.A., Sachs, G.S., Thase, M.E., 2006. Predictors of recurrence in
and illness recurrence in bipolar depression. Am. J. Med. Genet. B Neuropsy- bipolar disorder: primary outcomes from the Systematic Treatment Enhance-
chiatr. Genet. 123B, 23–26. ment Program for Bipolar Disorder (STEP-BD). Am. J. Psychiat. 163, 217–224.
Blanco, C., Laje, G., Olfson, M., Marcus, S.C., Pincus, H.A., 2002. Trends in the Perugi, G., Passino, M.C., Toni, C., Maremmani, I., Angst, J., 2007. Is unipolar mania a
treatment of bipolar disorder by outpatient psychiatrists. Am. J. Psychiat. distinct subtype? Compr. Psychiat. 48, 213–217.
159, 1005–1010. Pfohl, B., Vasquez, N., Nasrallah, H., 1982. Unipolar vs. bipolar mania: a review of
Carvalho, A.F., Dimellis, D., Gonda, X., Vieta, E., McLntyre, R.S., Fountoulakis, K.N., 247 patients. Br. J. Psychiat. 141, 453–458.
2014. Rapid cycling in bipolar disorder: a systematic review. J. Clin. Psychiat. Pompili, M., Serafini, G., Del Casale, A., Rigucci, S., Innamorati, M., Girardi, P.,
75, e578–e586. Tatarelli, R., Lester, D., 2009. Improving adherence in mood disorders: the
Chopra, M.P., Kishore Kumar, K.V., Subbakrishna, D.K., Jain, S., Murthy, R.S., 2006. struggle against relapse, recurrence and suicide risk. Exp. Rev. Neurother. 9,
The course of bipolar disorder in rural India. Indian J. Psychiat. 48, 254–257. 985–1004.
Colom, F., Vieta, E., Daban, C., Pacchiarotti, I., Sanchez-Moreno, J., 2006. Clinical and Popovic, D., Torrent, C., Goikolea, J.M., Cruz, N., Sanchez-Moreno, J., Gonzalez-Pinto,
therapeutic implications of predominant polarity in bipolar disorder. J. Affect. A., Vieta, E., 2014. Clinical implications of predominant polarity and the polarity
Disord. 93, 13–17. index in bipolar disorder: a naturalistic study. Acta Psychiat. Scand. 129,
Fekadu, A., Kebede, D., Alem, A., Fekadu, D., Mogga, S., Negash, A., Medhin, G., 366–374.
Beyero, T., Shibre, T., 2006. Clinical outcome in bipolar disorder in a commu- Post, R.M., Denicoff, K.D., Leverich, G.S., Altshuler, L.L., Frye, M.A., Suppes, T.M., Rush,
nity-based follow-up study in Butajira Ethiopia. Acta Psychiatr. Scand. 114, A.J., Keck Jr., P.E., McElroy, S.L., Luckenbaugh, D.A., Pollio, C., Kupka, R., Nolen,
426–434. W.A., 2003. Morbidity in 258 bipolar outpatients followed for 1 year with
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., Davies, M., Borus, J., Howes, daily prospective ratings on the NIMH life chart method. J. Clin. Psychiat. 64,
M.J., Kane, J., Pope, H.G., Rounsaville, B., 1995. The structured clinical interview 680–690, quiz 738-689.
for DSM-III-R personality disorders (SCID-II). Part II: multi-site test-retest Rajeev, J., Srinath, S., Girimaji, S., Seshadri, S.P., Singh, P., 2004. A systematic
reliability study. J. Pers. Disord. 9, 92–104. chart review of the naturalistic course and treatment of early-onset bipolar
Ghaemi, S.N., Hsu, D.J., Soldani, F., Goodwin, F.K., 2003. Antidepressants in bipolar disorder in a child and adolescent psychiatry center. Compr. Psychiat. 45,
disorder: the case for caution. Bipolar Disord. 5, 421–433. 148–154.
Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology. In: US Dept Roy-Byrne, P., Post, R.M., Uhde, T.W., Porcu, T., Davis, D., 1985. The longitudinal
Health, Education and Welfare Publication (ADM) 76-338National Institute of course of recurrent affective illness: life chart data from research patients at the
Mental Health, Rockville, Md, pp. 218–222. NIMH. Acta Psychiatr. Scand. Suppl. 317, 1–34.
Hamilton, M., 1960. A rating scale for depression. J. Neurol. Neurosurg. Psychiat. 23, Roybal, K., Theobold, D., Graham, A., DiNieri, J.A., Russo, S.J., Krishnan, V., Chakra-
56–62. varty, S., Peevey, J., Oehrlein, N., Birnbaum, S., Vitaterna, M.H., Orsulak, P.,
Jairam, R., Srinath, S., Girimaji, S.C., Seshadri, S.P., 2004. A prospective 4-5 year Takahashi, J.S., Nestler, E.J., Carlezon Jr., W.A., McClung, C.A., 2007. Mania-like
follow-up of juvenile onset bipolar disorder. Bipolar Disord. 6, 386–394. behavior induced by disruption of CLOCK. Proc. Natl. Acad. Sci. USA 104,
Judd, L.L., Akiskal, H.S., Schettler, P.J., Endicott, J., Maser, J., Solomon, D.A., Leon, A.C., 6406–6411.
Rice, J.A., Keller, M.B., 2002. The long-term natural history of the weekly Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E.,
symptomatic status of bipolar I disorder. Arch. Gen. Psychiat. 59, 530–537. Hergueta, T., Baker, R., Dunbar, G.C., 1998. The Mini-International Neuropsy-
Khanna, R., Gupta, N., Shanker, S., 1992. Course of bipolar disorder in eastern India. J. chiatric Interview (M.I.N.I.): the development and validation of a structured
Affect. Disord. 24, 35–41. diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiat. 59
Khess, C.R., Das, J., Akhtar, S., 1997. Four year follow-up of first episode manic (Suppl 20), 22–33, quiz 34-57.
patients. Indian J. Psychiat. 39, 160–165. Shulman, K.I., Tohen, M., 1994. Unipolar mania reconsidered: evidence from an
Kupka, R.W., Altshuler, L.L., Nolen, W.A., Suppes, T., Luckenbaugh, D.A., Leverich, elderly cohort. Br. J. Psychiat. 164, 547–549.
G.S., Frye, M.A., Keck Jr., P.E., McElroy, S.L., Grunze, H., Post, R.M., 2007. Three Solomon, D.A., Leon, A.C., Endicott, J., Coryell, W.H., Mueller, T.I., Posternak, M.A.,
times more days depressed than manic or hypomanic in both bipolar I and Keller, M.B., 2003. Unipolar mania over the course of a 20-year follow-up study.
bipolar II disorder. Bipolar Disord. 9, 531–535. Am. J. Psychiat. 160, 2049–2051.
S.B. Rangappa et al. / Asian Journal of Psychiatry 22 (2016) 22–27 27
Tohen, M., Frank, E., Bowden, C.L., Colom, F., Ghaemi, S.N., Yatham, L.N., Malhi, G.S., Wehr, T.A., Sack, D.A., Rosenthal, N.E., Cowdry, R.W., 1988. Rapid cycling affective
Calabrese, J.R., Nolen, W.A., Vieta, E., Kapczinski, F., Goodwin, G.M., Suppes, T., Sachs, disorder: contributing factors and treatment responses in 51 patients. Am. J.
G.S., Chengappa, K.R., Grunze, H., Mitchell, P.B., Kanba, S., Berk, M., 2009. The Psychiat. 145, 179–184.
International Society for Bipolar Disorders (ISBD) Task Force report on the nomen- Winokur, G., Coryell, W., Akiskal, H.S., Endicott, J., Keller, M., Mueller, T., 1994.
clature of course and outcome in bipolar disorders. Bipolar Disord. 11, 453–473. Manic-depressive (bipolar) disorder: the course in light of a prospective ten-
Turvey, C.L., Coryell, W.H., Arndt, S., Solomon, D.A., Leon, A.C., Endicott, J., Mueller, year follow-up of 131 patients. Acta Psychiatr. Scand. 89, 102–110.
T., Keller, M., Akiskal, H., 1999. Polarity sequence, depression, and chronicity in Yatham, L.N., Maj, M., 2010. Bipolar Disorder: clinical and Neurobiological Founda-
bipolar I disorder. J. Nerv. Ment. Disord. 187, 181–187. tions. Wiley-Blackwell.
Volkert, J., Zierhut, K.C., Schiele, M.A., Wenzel, M., Kopf, J., Kittel-Schneider, S., Reif, Yazici, O., 2014. Unipolar mania: a distinct entity? J. Affect. Disord. 152-154, 52–56.
A., 2014. Predominant polarity in bipolar disorder and validation of the polarity Yazici, O., Kora, K., Ucok, A., Saylan, M., Ozdemir, O., Kiziltan, E., Ozpulat, T., 2002.
index in a German sample. BMC Psychiat. 14, 322. Unipolar mania: a distinct disorder? J. Affect. Disord. 71, 97–103.
Wehr, T.A., Goodwin, F.K., 1979. Rapid cycling in manic-depressives induced by Young, R.C., Biggs, J.T., Ziegler, V.E., Meyer, D.A., 1978. A rating scale for mania:
tricyclic antidepressants. Arch. Gen. Psychiat. 36, 555–559. reliability, validity and sensitivity. Br. J. Psychiat. 133, 429–435.